Vital Signs - The Path Towards Home Monitoring Reimbursement: The Bad, the Good and the End Result

 

Regular Price: USD 1,500

Special Price USD 1,050

30% OFF

* Required Fields

Regular Price: USD 1,500

Special Price USD 1,050

PAY BY INVOICE

Be the first to review this product

This issue of Vital Signs, released on August 18, 2008, provides an strategic overview of developments and trends in home monitoring reimbursement. Additionally, a company spotlight is provided for BodyTel Scientific, a company focused in providing solutions in core areas of telemonitoring and management systems for chronic diseases. Reimbursement and regulatory news from the FDA is also provided for the week of August 4, 2008.

Table of Contents

Vital Signs - The Path Towards Home Monitoring Reimbursement: The Bad, the Good and the End ResultVital Signs: 18 August 2008This week's issue:




Related Research

Release Date : 26-Sep-17

Region : North America

Release Date : 25-Sep-17

Region : North America

Release Date : 19-Sep-17

Region : North America

Release Date : 08-Sep-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.